Trial Profile
An Immunopharmacodynamic Phase 0/I Study of Rapamycin in Patients Undergoing Radical Cystectomy for Bladder Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Oct 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Bladder cancer
- Focus Pharmacodynamics
- 26 Nov 2014 New trial record